This inventor holds 1 USPTO granted patent. Top assignee: The J. David Gladstone Institutes. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Oliver Keppler: Innovator in HIV Research
Introduction
Oliver Keppler is a prominent inventor based in San Francisco, CA (US). He has made significant contributions to the field of HIV research through his innovative work in developing transgenic rodent models. His research aims to enhance the understanding of HIV infection and replication, which is crucial for developing new antiviral strategies.
Latest Patents
Keppler holds a patent for "Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor." This invention features transgenic rodent models for HIV, wherein the transgenic rodent or transgenic rodent cell has incorporated into its genome genes encoding a human CD4 receptor and a human chemokine receptor. The transgenic rats or mice developed through this invention are characterized by their susceptibility to HIV infection and their capability to express HIV structural genes. This innovative model is instrumental for studying the molecular basis of HIV infection, replication, and pathogenicity, as well as for testing new antiviral agents or vaccine strategies.
Career Highlights
Keppler is associated with the J. David Gladstone Institutes, where he continues to advance his research in HIV. His work has garnered attention for its potential impact on public health and the development of effective treatments for HIV.
Collaborations
Some of his notable coworkers include Robert E. Atchison and Mark A. Goldsmith. Their collaborative efforts contribute to the ongoing research and development in the field of HIV.
Conclusion
Oliver Keppler's innovative work in creating transgenic rodent models for HIV research represents a significant advancement in understanding and combating this virus. His contributions are vital for the future of antiviral research and vaccine development.